Biologics in Asthma
The expert panel discusses the use of biologics in treating asthma, explaining their mechanisms of action, differences, and target populations, while also examining trends in long-term efficacy and safety for patients with severe or uncontrolled asthma.
EP: 1.External Factors and Seasonality of Asthma
EP: 2.Endotypes and Phenotypes in Asthma
EP: 3.Type 2 Inflammation and Biomarkers in Asthma
EP: 4.Moderate/Severe/Uncontrolled Asthma Classification
EP: 5.Thinking About Endotypes when Managing Asthma
EP: 6.Use of Oral Corticosteroids in Asthma
EP: 7.High Oral Corticosteroid Dose and Exposure in Asthma
EP: 8.Oral Corticosteroid Overuse and Uncontrolled Asthma
EP: 9.Biomarkers and Eosinophil Levels in Severe or Uncontrolled Asthma
Now Viewing
EP: 10.Biologics in Asthma
EP: 11.GINA Guidelines and Biologics for Treatment of Asthma
EP: 12.Use of Biologics for Asthma in Patients with Allergies
EP: 13.Treatment of Asthma in Pediatric Patients
EP: 14.Atopic March in Pediatric Patients
EP: 15.Use of Biologics in Pediatric Patients and Conversations with Parents
EP: 16.Biologic Options in Pediatric Asthma
EP: 17.Advice for Clinicians Managing Asthma
Video content above is prompted by the following question(s):
- A number of biologics are now available for treatment of asthma. Please provide an overview of how they work and in which patient populations they are most effective in.
- What trends are seen in long-term efficacy and safety of biologics in patients with severe or uncontrolled asthma?
Recent Videos
Related Content
